Latest Insider Transactions at Staar Surgical CO (STAA)
This section provides a real-time view of insider transactions for Staar Surgical CO (STAA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STAAR SURGICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STAAR SURGICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2021
|
Samuel J Gesten Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,682
+10.88%
|
$801,414
$27.37 P/Share
|
|
Aug 11
2021
|
Patrick F. Williams Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-7.52%
|
$350,000
$140.58 P/Share
|
|
Aug 10
2021
|
Lou Silverman |
SELL
Open market or private sale
|
Direct |
29,921
-77.33%
|
$4,338,545
$145.56 P/Share
|
|
Aug 10
2021
|
Lou Silverman |
BUY
Exercise of conversion of derivative security
|
Direct |
29,921
+43.61%
|
$269,289
$9.09 P/Share
|
|
Aug 10
2021
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,121
+13.35%
|
-
|
|
Jul 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Jul 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
655
-0.01%
|
-
|
|
Jun 28
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 28
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
130,000
-1.48%
|
$20,150,000
$155.19 P/Share
|
|
Jun 25
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 25
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,735
-0.35%
|
$4,763,925
$155.84 P/Share
|
|
Jun 24
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 24
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
67,708
-0.76%
|
$10,630,156
$157.83 P/Share
|
|
Jun 24
2021
|
Stephen C Farrell President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
404
+6.11%
|
-
|
|
Jun 24
2021
|
Thomas G Frinzi President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
807
+21.63%
|
-
|
|
Jun 24
2021
|
Gilbert H Kliman Director |
BUY
Grant, award, or other acquisition
|
Direct |
404
+11.92%
|
-
|
|
Jun 24
2021
|
Lou Silverman |
BUY
Exercise of conversion of derivative security
|
Direct |
807
+21.63%
|
-
|
|
Jun 24
2021
|
K Peony Yu Director |
BUY
Grant, award, or other acquisition
|
Direct |
404
+35.88%
|
-
|
|
Jun 18
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 18
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,236
-0.15%
|
$2,011,872
$152.59 P/Share
|
|
Jun 17
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 17
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
63,896
-0.71%
|
$9,584,400
$150.31 P/Share
|
|
Jun 16
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 16
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,543
-0.34%
|
$4,520,364
$148.79 P/Share
|
|
Jun 15
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 15
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
35,380
-0.39%
|
$5,200,860
$147.46 P/Share
|
|
Jun 14
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 14
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,895
-0.24%
|
$3,218,565
$147.79 P/Share
|
|
Jun 11
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 11
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,275
-0.03%
|
$334,425
$147.05 P/Share
|
|
Jun 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,014
-0.01%
|
$148,044
$146.36 P/Share
|
|
May 28
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 28
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
217,693
-2.35%
|
$32,000,871
$147.43 P/Share
|
|
May 28
2021
|
Stephen C Farrell President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-46.26%
|
$750,000
$150.0 P/Share
|
|
May 28
2021
|
Stephen C Farrell President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.63%
|
$25,000
$5.54 P/Share
|
|
May 27
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 27
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
47,571
-0.51%
|
$6,802,653
$143.42 P/Share
|
|
May 26
2021
|
Stephen C Farrell President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-46.26%
|
$675,000
$135.0 P/Share
|
|
May 26
2021
|
Stephen C Farrell President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.63%
|
$35,000
$7.14 P/Share
|
|
May 24
2021
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Open market or private sale
|
Direct |
94,855
-46.67%
|
$12,331,150
$130.42 P/Share
|
|
May 24
2021
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
94,855
+12.05%
|
$948,550
$10.08 P/Share
|
|
May 24
2021
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
14,500
-21.6%
|
$1,885,000
$130.42 P/Share
|
|
May 24
2021
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+17.76%
|
$232,000
$16.15 P/Share
|
|
May 21
2021
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Open market or private sale
|
Direct |
5,145
-4.53%
|
$658,560
$128.0 P/Share
|
|
May 21
2021
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
5,145
+2.21%
|
$56,595
$11.45 P/Share
|
|
May 21
2021
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
15,261
-22.48%
|
$1,922,886
$126.83 P/Share
|
|
May 21
2021
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
15,261
+18.35%
|
$137,349
$9.3 P/Share
|
|
May 21
2021
|
Scott D Barnes Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,295
-34.52%
|
$1,549,170
$126.05 P/Share
|
|
May 21
2021
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,295
+11.24%
|
$319,670
$26.55 P/Share
|